|
|
Volumn 2, Issue 8, 2001, Pages 1269-1274
|
|
Options for the pharmacotherapy of toxoplasmosis during pregnancy
a
|
|
Author keywords
Antenatal treatment efficacy; Congenital toxoplasmosis; Congenital transmission; Pyrimethamine; Sequelae; Spiramycin; Sulfonamides
|
|
Indexed keywords
ATOVAQUONE;
AZITHROMYCIN;
COTRIMOXAZOLE;
FANSIDAR;
FOLINIC ACID;
MACROLIDE;
PYRIMETHAMINE;
SPIRAMYCIN;
SULFADIAZINE;
SULFADOXINE;
SULFAMETHOXAZOLE;
TRIMETHOPRIM;
ALLERGIC REACTION;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANXIETY;
ATTITUDE;
AUSTRIA;
BONE MARROW SUPPRESSION;
CHEMOTHERAPY;
CLINICAL TRIAL;
CONGENITAL TOXOPLASMOSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG CEREBROSPINAL FLUID LEVEL;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG POTENTIATION;
EYE DISEASE;
FEMALE;
FRANCE;
GEOGRAPHIC DISTRIBUTION;
HUMAN;
INTRAUTERINE INFECTION;
MENTAL DEFICIENCY;
MULTICENTER STUDY;
NEPHROTOXICITY;
NONHUMAN;
NORWAY;
PHYSICIAN;
PREGNANCY DISORDER;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIAL;
RASH;
RELAPSE;
RETROSPECTIVE STUDY;
REVIEW;
SCREENING;
SECONDARY PREVENTION;
SEROCONVERSION;
SERODIAGNOSIS;
STILLBIRTH;
SYMPTOMATOLOGY;
TERATOGENICITY;
TOXOPLASMOSIS;
UNITED KINGDOM;
ANTIPROTOZOAL AGENTS;
FEMALE;
HUMANS;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY COMPLICATIONS, PARASITIC;
TOXOPLASMOSIS;
TOXOPLASMOSIS, CONGENITAL;
|
|
EID: 0034863642
PISSN: 14656566
EISSN: None
Source Type: Journal
DOI: 10.1517/14656566.2.8.1269 Document Type: Review |
|
Times cited : (17)
|
|
References (32)
|
